Pharmacology
-
Spotlight: Barrier breakers
By putting one foot in front of another, these trailblazers have changed Vanderbilt—and the world—with their dedication to basic research and breaking down barriers for themselves and others. Read MoreMar. 7, 2024
-
Five Basic Sciences faculty named to Vanderbilt University 2024 endowed chair cohort
Bruce Carter, Lisa Monteggia, Richard O’Brien, Andrea Page-McCaw, and Kevin Schey have been named endowed chairs, the highest academic award that Vanderbilt can give to a faculty member. Read MoreMar. 1, 2024
-
Celebrating recent appointments and promotions in Basic Sciences
We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read MoreJan. 24, 2024
-
Erin Calipari receives $2M to study how alcohol use disorder develops in the brain
Erin Calipari, associate professor of pharmacology and associate director of the Vanderbilt Center for Addiction Research, has received a grant of nearly $2 million from the National Institute on Alcohol Abuse and Alcoholism to understand what happens in the brain that makes… Read MoreSep. 13, 2023
-
Basic Sciences names Hodges, Siciliano as Dean’s Faculty Fellows
By Aaron Conley Emily Hodges, assistant professor of biochemistry, and Cody Siciliano, assistant professor of pharmacology, have been named Dean’s Faculty Fellows of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early… Read MoreAug. 18, 2023
-
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read MoreJul. 6, 2023
-
Study identifies key regulator of melanoma development
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity. Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known… Read MoreJun. 15, 2023
-
Targeting calcium handling in A-fib
Atrial fibrillation (A-fib) — the most common cardiac arrhythmia (irregular heartbeat) — is associated with increased risk of stroke, heart failure, dementia and death. Antiarrhythmic drug therapy to prevent A-fib has remained elusive. The strongest genetic risk factors for A-fib in humans are variants in a chromosomal region including the gene… Read MoreJun. 15, 2023
-
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79. Dr. Roberts, professor of Pharmacology and Medicine, emeritus, was perhaps best known… Read MoreJun. 6, 2023
-
Lindsley named 2022 fellow of American Society for Pharmacology and Experimental Therapeutics
Craig W. Lindsley, University Distinguished Professor of Pharmacology, Biochemistry and Chemistry, who holds the William K. Warren, Jr. Chair in Medicine, was recently announced as a 2022 fellow of the American Society for Pharmacology and Experimental Therapeutics for his demonstrated excellence and… Read MoreNov. 30, 2022